Jennifer Shah

University of Michigan — United States

Medicine · Health Sciences

14h-index1.1kcitations185works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(95), Radiomics and Machine Learning in Medical Imaging(30), Cancer Genomics and Diagnostics(25), RNA modifications and cancer(24), Hippo pathway signaling and YAP/TAZ(18)

Publications185 total

Supplementary Table 3 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
2026Open Access
Supplementary Table 1 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
2026Open Access
Supplementary Table 2 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
2026Open Access
Supplementary Table 4 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
2026Open Access
Supplementary Table 6 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
2026Open Access
Supplementary Table 5 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
2026Open Access
Short‐Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer‐Related Lymphedema: A Multi‐Site Randomized Clinical Trial
Head & Neck·2026Open Access
FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
Clinical Cancer Research·2025Open Access
Treatment Interruption and Outcomes in Head and Neck Cancer
JAMA Otolaryngology–Head & Neck Surgery·2025Open Access
Supplementary Table 5 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
2025Open Access
Supplementary Table 4 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
2025Open Access
Supplementary Table 2 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
2025Open Access
Supplementary Table 3 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
2025Open Access
Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
2025Open Access
Supplementary Table 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
2025Open Access
Parotid-Sparing Versus Conventional Whole Brain Radiation Therapy: A Multi-Institutional Randomized Clinical Trial
International Journal of Radiation Oncology*Biology*Physics·2025
Workflow and Treatment Volumes for UMCC2023.006: A Pilot Phase II Trial of Individualized FDG-PET and DCE-MRI Directed Adaptive RT in HPV-related Stage III Oropharynx Cancer (OPSCC)
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
HPV ctDNA Kinetics during Radiation and in Surveillance in a Phase II De-Escalation Trial for Early-Stage p16+ Oropharynx Cancer
International Journal of Radiation Oncology*Biology*Physics·2025
Prospective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx Cancer
Advances in Radiation Oncology·2025Open Access
Response adapted oncologic surgery following neoadjuvant immunotherapy and chemotherapy for resectable locally advanced oral cavity and oropharyngeal squamous cell carcinoma.
Journal of Clinical Oncology·2025· 1 cited
page 1 of 10Next →

Frequent Co-authors

Michelle Mierzwa(22), Keith Casper(18), Paul Swiecicki(17), Matthew E. Spector(16), Caitlin A. Schonewolf(16), Kelly M. Malloy(15), Mark E. Prince(15), Francis P. Worden(15), Andrew G. Shuman(14), Chaz L. Stucken(14), Steven B. Chinn(13), Andrew J. Rosko(13), J. Chad Brenner(11), Avraham Eisbruch(9), David J. Sher(8), Yue Cao(7), Madhava Aryal(7), Laila A. Gharzai(7), Carol R. Bradford(7), Matthew J. Schipper(6)